American Thought Leaders Behind the Curtain of the New CDC Panel on Vaccines: Dr. Robert Malone and Retsef Levi
Jul 6, 2025
Dr. Robert Malone, a prominent physician and biochemist known for mRNA vaccine technology, and Retsef Levi, an MIT professor specializing in data science, delve into the recent shifts in the CDC's Advisory Committee on Immunization Practices. They tackle critical topics like thimerosal in flu vaccines and RSV shots for children, emphasizing the financial motives impacting vaccine decisions. The duo advocates for transparency and improved patient-centered care, critiquing current public health decision-making and the necessity for rigorous data in evaluating vaccine safety.
AI Snips
Chapters
Books
Transcript
Episode notes
ACIP's Major Influence Explained
- ACIP advises CDC on infectious disease countermeasures, impacting billions of dollars in vaccine industry revenue.
- It functionally sets vaccine standards of care, affecting insurance coverage and medical liability risks.
Value of Diversity in ACIP
- Risk-benefit analysis is crucial for vaccine policy and personalized decisions.
- Diverse expertise in ACIP enhances decision-making beyond simple narratives.
Dr. Malone's Vaccine Expertise
- Dr. Malone shared his 30-year experience in infectious disease and vaccine development.
- He highlighted working with current HHS Secretary Robert F. Kennedy Jr. and his commitment to serving on ACIP.
